Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Kyle Rove

Concepts (286)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urologic Surgical Procedures
11
2024
107
3.650
 Why?
Prostatic Neoplasms
17
2014
1016
3.000
 Why?
Androgen Antagonists
5
2014
79
1.960
 Why?
Perioperative Care
3
2024
150
1.880
 Why?
Urology
5
2024
57
1.790
 Why?
Analgesics, Opioid
8
2024
889
1.770
 Why?
Pain, Postoperative
5
2024
222
1.770
 Why?
Urinary Bladder, Neurogenic
3
2024
35
1.560
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2024
335
1.380
 Why?
Urinary Bladder
4
2022
175
1.280
 Why?
Postoperative Complications
9
2024
2462
1.280
 Why?
Urodynamics
3
2024
35
1.140
 Why?
Testosterone
5
2015
370
1.110
 Why?
Urinary Bladder Neoplasms
3
2017
226
0.940
 Why?
Abdominal Neoplasms
1
2024
34
0.930
 Why?
Testicular Neoplasms
2
2016
104
0.920
 Why?
Practice Patterns, Physicians'
3
2024
1262
0.900
 Why?
Specialties, Surgical
1
2025
73
0.880
 Why?
Physicians, Women
1
2025
70
0.880
 Why?
Neoplasms, Hormone-Dependent
2
2014
38
0.860
 Why?
Surgeons
2
2025
259
0.850
 Why?
Propensity Score
1
2024
265
0.810
 Why?
Child
27
2024
20805
0.810
 Why?
Delphi Technique
1
2024
222
0.810
 Why?
Urinary Bladder Diseases
1
2022
18
0.810
 Why?
Drug Prescriptions
1
2024
245
0.800
 Why?
Pediatrics
3
2024
1050
0.790
 Why?
Ureter
1
2022
35
0.780
 Why?
Gonadotropin-Releasing Hormone
3
2014
207
0.760
 Why?
Consensus
2
2024
610
0.760
 Why?
Postoperative Nausea and Vomiting
1
2020
11
0.710
 Why?
Urologic Diseases
2
2018
38
0.710
 Why?
Length of Stay
8
2024
1119
0.700
 Why?
Spinal Dysraphism
2
2022
59
0.700
 Why?
Analgesia
1
2020
92
0.660
 Why?
Renal Insufficiency, Chronic
1
2024
564
0.610
 Why?
Humans
58
2025
128499
0.600
 Why?
Wolfram Syndrome
1
2018
4
0.600
 Why?
Pons
1
2018
30
0.590
 Why?
Bone Neoplasms
2
2011
231
0.590
 Why?
Urination
1
2018
44
0.580
 Why?
Electronic Health Records
2
2025
974
0.580
 Why?
Male
36
2025
63045
0.570
 Why?
Prostate-Specific Antigen
4
2014
162
0.570
 Why?
Lower Urinary Tract Symptoms
1
2018
54
0.550
 Why?
Prospective Studies
11
2024
7069
0.550
 Why?
Recovery of Function
2
2018
633
0.550
 Why?
Sertoli-Leydig Cell Tumor
1
2016
8
0.530
 Why?
Bariatric Surgery
1
2020
192
0.530
 Why?
Acute Kidney Injury
1
2024
779
0.530
 Why?
Cystoscopy
1
2016
18
0.520
 Why?
Evidence-Based Medicine
2
2018
712
0.510
 Why?
Sex Cord-Gonadal Stromal Tumors
1
2015
5
0.500
 Why?
Child, Preschool
10
2024
10487
0.500
 Why?
Cause of Death
2
2023
392
0.500
 Why?
Prostate
2
2012
180
0.440
 Why?
Patient Care Team
2
2018
598
0.430
 Why?
Hyperoxaluria, Primary
2
2023
14
0.410
 Why?
Kidney Calculi
2
2023
35
0.410
 Why?
Pediatric Obesity
1
2020
570
0.400
 Why?
Incidence
4
2024
2638
0.400
 Why?
Tonsillectomy
2
2024
79
0.400
 Why?
Antineoplastic Agents, Hormonal
1
2013
158
0.390
 Why?
Referral and Consultation
1
2017
728
0.380
 Why?
Retrospective Studies
13
2025
14472
0.380
 Why?
Adolescent
12
2024
20304
0.370
 Why?
Azasteroids
1
2011
4
0.360
 Why?
5-alpha Reductase Inhibitors
1
2011
16
0.360
 Why?
Orchiectomy
3
2016
65
0.360
 Why?
Disease Progression
4
2015
2604
0.350
 Why?
Kidney Neoplasms
3
2019
350
0.350
 Why?
Anticarcinogenic Agents
1
2011
77
0.340
 Why?
Sleep Apnea, Obstructive
2
2024
238
0.340
 Why?
Registries
1
2018
1883
0.330
 Why?
Risk Assessment
4
2024
3232
0.320
 Why?
Neoplasm Staging
4
2016
1292
0.300
 Why?
Early Detection of Cancer
2
2011
369
0.300
 Why?
Wilms Tumor
2
2019
77
0.290
 Why?
Female
15
2025
68268
0.280
 Why?
Adenoidectomy
2
2024
66
0.270
 Why?
Sex Factors
2
2025
1951
0.250
 Why?
Antineoplastic Agents
3
2012
2042
0.250
 Why?
Case-Control Studies
3
2023
3339
0.240
 Why?
Fractures, Bone
1
2009
393
0.220
 Why?
Prognosis
3
2018
3780
0.220
 Why?
Nephrocalcinosis
1
2023
3
0.220
 Why?
Nephrolithiasis
1
2023
10
0.220
 Why?
Young Adult
6
2024
12349
0.220
 Why?
Neoplasm Metastasis
2
2016
610
0.210
 Why?
Ureteral Calculi
1
2023
13
0.210
 Why?
Lithotripsy
1
2023
43
0.200
 Why?
Analgesia, Epidural
1
2022
23
0.200
 Why?
Meningomyelocele
1
2023
58
0.190
 Why?
Survival Analysis
2
2016
1265
0.190
 Why?
Hydrocephalus
1
2023
108
0.190
 Why?
Stents
2
2023
504
0.190
 Why?
Device Removal
1
2022
134
0.180
 Why?
Cohort Studies
2
2024
5402
0.180
 Why?
Diphosphonates
2
2011
56
0.170
 Why?
RANK Ligand
2
2010
27
0.170
 Why?
Treatment Outcome
6
2023
10162
0.170
 Why?
Radiotherapy
2
2012
186
0.170
 Why?
Anastomosis, Surgical
1
2020
149
0.170
 Why?
Age Factors
2
2018
3122
0.170
 Why?
Combined Modality Therapy
2
2014
1201
0.170
 Why?
Caregivers
2
2024
813
0.160
 Why?
Sex-Determining Region Y Protein
1
2019
2
0.160
 Why?
WT1 Proteins
1
2019
14
0.160
 Why?
Emotions
1
2024
535
0.160
 Why?
Nephrotic Syndrome
1
2019
28
0.160
 Why?
Disorders of Sex Development
1
2019
39
0.150
 Why?
Urethral Neoplasms
1
2018
1
0.150
 Why?
Magnetic Resonance Imaging
3
2019
3387
0.150
 Why?
Hypertension, Renal
1
2018
16
0.150
 Why?
Follow-Up Studies
3
2018
4874
0.150
 Why?
Paraganglioma, Extra-Adrenal
1
2018
7
0.150
 Why?
Urethral Obstruction
1
2018
9
0.150
 Why?
Polyps
1
2018
11
0.150
 Why?
Renal Artery Obstruction
1
2018
29
0.150
 Why?
Surveys and Questionnaires
4
2024
5371
0.150
 Why?
Urethra
1
2018
52
0.140
 Why?
Kidney Failure, Chronic
1
2023
541
0.140
 Why?
Prenatal Diagnosis
1
2019
190
0.140
 Why?
Practice Guidelines as Topic
2
2018
1490
0.140
 Why?
Adult
8
2024
35302
0.140
 Why?
Pain Management
1
2020
321
0.140
 Why?
Intestines
1
2020
344
0.140
 Why?
Decision Making
1
2024
847
0.140
 Why?
Organ Size
1
2018
441
0.140
 Why?
Men's Health
1
2017
7
0.140
 Why?
Infant
2
2024
9001
0.140
 Why?
Postoperative Period
1
2018
324
0.130
 Why?
Immunotherapy
2
2011
589
0.130
 Why?
Review Literature as Topic
1
2017
66
0.130
 Why?
Tertiary Care Centers
1
2017
150
0.130
 Why?
Databases, Factual
2
2022
1267
0.130
 Why?
Feminization
1
2015
6
0.130
 Why?
Mitotic Index
1
2015
26
0.130
 Why?
Intermittent Urethral Catheterization
1
2015
3
0.120
 Why?
Urination Disorders
1
2015
13
0.120
 Why?
Ultrasonography
3
2019
712
0.120
 Why?
Colorectal Neoplasms
1
2022
751
0.120
 Why?
Cloaca
1
2015
48
0.120
 Why?
Neoplasm Invasiveness
1
2016
478
0.120
 Why?
Disease-Free Survival
1
2016
647
0.120
 Why?
Patient Reported Outcome Measures
1
2018
370
0.110
 Why?
Antibodies, Monoclonal
2
2011
1357
0.110
 Why?
Kaplan-Meier Estimate
1
2016
856
0.110
 Why?
Risk Factors
3
2018
9737
0.110
 Why?
Self Report
1
2018
797
0.110
 Why?
Image Processing, Computer-Assisted
1
2018
737
0.110
 Why?
Infant, Newborn
4
2019
5740
0.110
 Why?
Creatinine
1
2015
480
0.100
 Why?
Estrogens
1
2015
342
0.100
 Why?
Quality of Life
2
2018
2688
0.100
 Why?
Telemedicine
1
2021
786
0.100
 Why?
Radiation-Protective Agents
1
2012
26
0.100
 Why?
Multivariate Analysis
1
2016
1499
0.100
 Why?
Drug Design
1
2013
155
0.100
 Why?
Alpha Particles
1
2011
1
0.100
 Why?
Beta Particles
1
2011
1
0.100
 Why?
Metalloporphyrins
1
2012
101
0.100
 Why?
Endothelin A Receptor Antagonists
1
2011
24
0.100
 Why?
Clusterin
1
2011
11
0.100
 Why?
Kidney
2
2019
1310
0.100
 Why?
Blood Chemical Analysis
1
2012
94
0.100
 Why?
Receptors, Androgen
1
2013
143
0.100
 Why?
Mitomycin
1
2011
31
0.090
 Why?
Drug Costs
1
2012
100
0.090
 Why?
Valproic Acid
1
2011
47
0.090
 Why?
Dutasteride
1
2011
4
0.090
 Why?
Logistic Models
1
2016
1980
0.090
 Why?
Carcinoma, Transitional Cell
1
2011
60
0.090
 Why?
Bone Density Conservation Agents
1
2011
71
0.090
 Why?
Androstenols
1
2010
4
0.090
 Why?
Denosumab
1
2010
8
0.090
 Why?
Tissue Extracts
1
2010
19
0.090
 Why?
Antibiotics, Antineoplastic
1
2011
120
0.090
 Why?
Imaging, Three-Dimensional
2
2012
529
0.090
 Why?
Guideline Adherence
1
2015
524
0.090
 Why?
Prostatic Hyperplasia
1
2011
42
0.090
 Why?
Androstenes
1
2010
17
0.090
 Why?
Dihydrotestosterone
1
2011
39
0.090
 Why?
Longitudinal Studies
1
2018
2710
0.090
 Why?
Patient Care Management
1
2011
56
0.090
 Why?
Biomedical Research
1
2017
633
0.090
 Why?
Phenylthiohydantoin
1
2010
44
0.090
 Why?
Taxoids
1
2010
98
0.090
 Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2010
2
0.090
 Why?
Nitriles
1
2010
160
0.080
 Why?
Benzamides
1
2010
195
0.080
 Why?
Antigens, Neoplasm
1
2012
308
0.080
 Why?
Histone Deacetylase Inhibitors
1
2011
209
0.080
 Why?
Hormone Antagonists
1
2009
31
0.080
 Why?
Cost-Benefit Analysis
1
2012
569
0.080
 Why?
Mobility Limitation
1
2009
58
0.080
 Why?
Bone Remodeling
1
2009
71
0.080
 Why?
Collagen Type I
1
2009
118
0.080
 Why?
Risk
1
2011
853
0.080
 Why?
Antioxidants
1
2012
545
0.080
 Why?
Middle Aged
6
2016
30923
0.080
 Why?
Aged
4
2016
21976
0.080
 Why?
Continuity of Patient Care
1
2011
275
0.080
 Why?
Drug Resistance, Neoplasm
1
2013
749
0.070
 Why?
Mutation
1
2019
3696
0.070
 Why?
Biomarkers, Tumor
1
2014
1179
0.070
 Why?
Computer Simulation
1
2011
939
0.070
 Why?
Software
1
2011
608
0.060
 Why?
Randomized Controlled Trials as Topic
1
2011
1358
0.060
 Why?
Protein Kinase Inhibitors
1
2011
880
0.060
 Why?
Antibodies, Monoclonal, Humanized
1
2010
758
0.060
 Why?
Peptides
1
2009
915
0.060
 Why?
Mass Screening
1
2011
1146
0.060
 Why?
Calcium Oxalate
1
2023
5
0.050
 Why?
Ambulatory Surgical Procedures
1
2024
55
0.050
 Why?
Polysomnography
1
2024
161
0.050
 Why?
Ureteroscopy
1
2023
16
0.050
 Why?
Predictive Value of Tests
2
2022
1938
0.050
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
1562
0.050
 Why?
Ventriculoperitoneal Shunt
1
2023
38
0.050
 Why?
Colostomy
1
2022
26
0.050
 Why?
Animals
3
2013
34647
0.050
 Why?
Morphine
1
2022
127
0.050
 Why?
Multicenter Studies as Topic
1
2022
286
0.050
 Why?
Internship and Residency
1
2011
1045
0.050
 Why?
Urologists
1
2021
17
0.040
 Why?
United States
1
2017
13840
0.040
 Why?
Feasibility Studies
1
2023
863
0.040
 Why?
Signal Transduction
1
2013
4825
0.040
 Why?
Oxygen
1
2023
901
0.040
 Why?
Cytoskeletal Proteins
1
2019
145
0.040
 Why?
Patient Readmission
1
2024
665
0.040
 Why?
Pilot Projects
1
2023
1568
0.040
 Why?
Normetanephrine
1
2018
2
0.040
 Why?
Metanephrine
1
2018
2
0.040
 Why?
Cystography
1
2018
1
0.040
 Why?
Renin
1
2018
31
0.040
 Why?
Lymph Node Excision
1
2019
164
0.040
 Why?
Urinary Retention
1
2018
20
0.040
 Why?
Nephrectomy
1
2019
158
0.040
 Why?
Chemotherapy, Adjuvant
1
2019
381
0.040
 Why?
DNA Mutational Analysis
1
2019
385
0.040
 Why?
Abnormalities, Multiple
1
2019
178
0.030
 Why?
Norepinephrine
1
2018
210
0.030
 Why?
Patient Satisfaction
1
2021
626
0.030
 Why?
Epithelium
1
2018
306
0.030
 Why?
Computed Tomography Angiography
1
2018
115
0.030
 Why?
Global Burden of Disease
1
2017
18
0.030
 Why?
Urologic Neoplasms
1
2017
25
0.030
 Why?
Infertility, Male
1
2017
60
0.030
 Why?
Quality-Adjusted Life Years
1
2017
106
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2019
392
0.030
 Why?
Genetic Testing
1
2019
428
0.030
 Why?
Statistics, Nonparametric
1
2017
419
0.030
 Why?
Endoscopy
1
2018
271
0.030
 Why?
Urinary Diversion
1
2015
12
0.030
 Why?
Kidney Function Tests
1
2015
145
0.030
 Why?
Diagnosis, Differential
1
2019
1412
0.030
 Why?
Pandemics
1
2021
1477
0.030
 Why?
Image-Guided Biopsy
1
2012
37
0.030
 Why?
Penis
1
2012
35
0.020
 Why?
Erectile Dysfunction
1
2012
39
0.020
 Why?
Radiation, Ionizing
1
2012
76
0.020
 Why?
Prostatectomy
1
2012
106
0.020
 Why?
Testis
1
2012
144
0.020
 Why?
Emergency Service, Hospital
1
2023
1900
0.020
 Why?
Neoplasm Grading
1
2012
285
0.020
 Why?
Glomerular Filtration Rate
1
2015
684
0.020
 Why?
Cross-Sectional Studies
1
2022
5045
0.020
 Why?
Drug Synergism
1
2011
357
0.020
 Why?
Biopsy, Needle
1
2011
187
0.020
 Why?
Efficiency
1
2011
91
0.020
 Why?
DNA Damage
1
2012
370
0.020
 Why?
Tumor Cells, Cultured
1
2011
930
0.020
 Why?
Reference Values
1
2011
780
0.020
 Why?
Workload
1
2011
151
0.020
 Why?
Tomography, X-Ray Computed
1
2019
2517
0.020
 Why?
Safety
1
2011
328
0.020
 Why?
Drug Therapy, Combination
1
2011
1016
0.020
 Why?
Skin
1
2012
717
0.020
 Why?
Rats, Sprague-Dawley
1
2012
2272
0.020
 Why?
Pregnancy
1
2019
6373
0.020
 Why?
Time Factors
1
2017
6506
0.020
 Why?
Models, Biological
1
2012
1698
0.010
 Why?
Rats
1
2012
5246
0.010
 Why?
Reproducibility of Results
1
2011
3021
0.010
 Why?
Rove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (286) concept(s)
_
Co-Authors Expand Description
See all (36) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)